Article Information
vol. 32 no. 167
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 14, 2022
- Accepted December 31, 2022
- Published online March 8, 2023.
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Rupsha Fraser1⇑,
- Aurelio Orta-Resendiz2,
- David Dockrell1,
- Michaela Müller-Trutwin2 and
- Alexander Mazein3
- 1The University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK
- 2Institut Pasteur, Université Paris Cité, HIV, Inflammation and Persistence Unit, Paris, France
- 3Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg
- Corresponding author: Rupsha Fraser (rupsha.fraser{at}ed.ac.uk)
Article usage
Altmetrics
Vol 32 Issue 167
Table of Contents
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Jump To
- Article
- Abstract
- Abstract
- Introduction
- SARS-CoV-2 viral entry and primary host response to infection
- Clinical characteristics of the COVID-19 spectrum and MIS
- Immunopathogenesis of SARS-CoV-2-induced disease phenotypes
- Aetiology and immunological evolution of severe COVID-19 versus MIS
- Conclusion
- Acknowledgements
- Footnotes
- References
- Figures & Data
- Info & Metrics